Research Frontiers Incorporated (REFR)
NASDAQ: REFR · Real-Time Price · USD
0.946
-0.034 (-3.46%)
Mar 9, 2026, 3:45 PM EDT - Market open
Research Frontiers Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 33 | 44 | 57 | 34 | 63 | 54 | |
| Market Cap Growth | -29.66% | -23.09% | 69.35% | -46.55% | 16.31% | -38.65% | |
| Enterprise Value | 33 | 44 | 56 | 31 | 59 | 52 | |
| Last Close Price | 0.98 | 1.31 | 1.71 | 1.01 | 1.91 | 1.72 | |
| PS Ratio | 29.33 | 39.31 | 42.92 | 37.21 | 117.32 | 43.10 | |
| PB Ratio | 35.32 | 47.21 | 22.01 | 9.62 | 13.20 | 14.39 | |
| P/TBV Ratio | 35.23 | 47.21 | 22.01 | 9.62 | 13.20 | 14.39 | |
| EV/Sales Ratio | 29.78 | 39.37 | 41.76 | 34.23 | 109.38 | 41.28 | |
| Debt / Equity Ratio | 1.25 | 1.25 | 0.50 | 0.08 | 0.10 | 0.17 | |
| Net Debt / Equity Ratio | 0.54 | 0.54 | -0.27 | -0.63 | -0.78 | -0.63 | |
| Net Debt / EBITDA Ratio | -0.24 | -0.24 | 0.49 | 1.10 | 1.45 | 1.32 | |
| Net Debt / FCF Ratio | -0.38 | -0.38 | 0.88 | 0.96 | 1.73 | 1.32 | |
| Asset Turnover | 0.36 | 0.36 | 0.34 | 0.20 | 0.11 | 0.24 | |
| Quick Ratio | 3.60 | 3.60 | 9.86 | 12.54 | 15.97 | 12.95 | |
| Current Ratio | 3.84 | 3.84 | 10.21 | 12.89 | 16.30 | 13.26 | |
| Return on Equity (ROE) | -115.64% | -115.64% | -42.84% | -45.90% | -62.22% | -40.53% | |
| Return on Assets (ROA) | -42.36% | -42.36% | -22.84% | -27.58% | -33.10% | -21.39% | |
| Return on Capital Employed (ROCE) | -109.10% | -109.10% | -38.20% | -56.90% | -51.80% | -43.30% | |
| Earnings Yield | -6.22% | -4.64% | -2.29% | -5.64% | -4.22% | -3.39% | |
| FCF Yield | -4.04% | -3.02% | -1.38% | -6.79% | -3.45% | -3.32% | |
| Buyback Yield / Dilution | -1.71% | -1.71% | -0.20% | -4.31% | -1.34% | -0.50% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.